Evidence map›Paper›PMID 41595498›Full record

ArticleGenes2026

Interdependent Regulation of Alternative Splicing by Serine/Arginine-Rich and Heterogeneous Nuclear Ribonucleoprotein Splicing Factors.

Megan E Holmes, Klemens J Hertel

Abstract read
In one paragraph

Article in Genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. The Co-Expression ofPlants (Basel, Switzerland) · 2026
    Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Megan E HolmesDepartment of Microbiology and Molecular Genetics, University of California Irvine, Irvine, CA 92697, USA.ORCID 0009-0008-1200-8778
Klemens J HertelDepartment of Microbiology and Molecular Genetics, University of California Irvine, Irvine, CA 92697, USA.ORCID 0000-0002-7560-9529

Funding

Regulation and impact of alternative splicing in biology and diseaseR35GM145254 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI Klemens J Hertel · 2022 to 2026
$2.4M
NIGMS NIH HHS R35 GM145254NIH HHS R35 GM145254
6 · The paper itself

Abstract

backgroundAlternative pre-mRNA splicing is a combinatorial process involving serine/arginine-rich (SR) and heterogeneous nuclear ribonucleoprotein (hnRNP) splicing factors. These proteins can silence or enhance splicing based on their expression levels and binding positions.

objectivesTo better understand the combinatorial and interdependent regulation between SR and hnRNP splicing factors during alternative splicing.

methodsComputational analyses were performed using cell knockdown and binding datasets from available databases.

resultsAnalyses of differential splicing data for 9 SR proteins and 21 hnRNP knockdowns revealed statistically significant interdependent regulation among several RNA-binding protein (RBP) combinations, albeit at different levels. Neither SR proteins nor hnRNPs showed strong preferences for collaborating with specific RBP classes in mediating exon inclusion. While SRSF3, hnRNPK, hnRNPC, and hnRNPL stand out as major influencers of alternative splicing, they do so predominantly independent of other RBPs. Minor influencers of alternative splicing, such as hnRNPDL and hnRNPR, predominantly regulate exon inclusion in concert with other RBPs, indicating that exon inclusion can be mediated by both single and multiple RBPs. Interestingly, the higher the number of RBPs that regulate the inclusion of an exon, the more variable exon inclusion preferences become. Interdependently regulated exons are more modular and can be characterized by weaker splice sites compared to their independently regulated counterparts. A comparison of RBP interdependence between HeLa and other cell lines provides a framework that explains cell-type-specific alternative splicing.

conclusionsOur study highlights the importance of the interdependent regulation of alternative exons and identifies characteristics of interdependently regulated exons that differ from independently regulated exons.

Indexed as

Alternative SplicingHeterogeneous-Nuclear RibonucleoproteinsRNA Splicing FactorsSerine-Arginine Splicing FactorsExonsHeLa CellsHumansRNA-Binding ProteinsRNA PrecursorsHeterogeneous-Nuclear RibonucleoproteinsRNA-Binding ProteinsRNA PrecursorsRNA Splicing FactorsSerine-Arginine Splicing Factorsalternative splicingexon inclusionhnRNPsSR proteins

Identifiers

PMID41595498
PMCPMC12840759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.